Spironolactone
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Spironolactone Product Information
Spironolactone is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Spironolactone. The product is supplied by Clearsynth under CAT No. CS-O-30758.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Spironolactone
CAS No.
52-01-7
CAT No.
CS-O-30758
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C24H32O4S
Molecular Weight
416.57
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Spironolactone is supplied with detailed characterization data compliant with regulatory guideline. Spironolactone can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Spironolactone.
Overview
"Spironolactone is an Aldosterone Antagonist. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of "
Synonyms
Spironolactone
Application Notes
"Spironolactone is an Aldosterone Antagonist. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of "
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.